Mill Creek Capital Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1964962 Conshohocken, PA

Position in LLY

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$564,738

-$29,560 QoQ

Shares Held

614

+11.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Mill Creek Capital Advisors, LLC holds $59,193,747 across 6 Drug Manufacturers - General names. LLY ranks #4 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	227,635	$55,643,099
2	AMGN	Amgen Inc	4,238	$1,491,140
3	MRK	Merck & Co., Inc.	5,935	$713,921
4	LLY	ELI LILLY & Co This page	614	$564,738
5	ABBV	AbbVie Inc.	1,821	$396,049
6	GILD	Gilead Sciences, Inc.	2,761	$384,800

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$564,738	614	+11.0%	Shares	Sole	2026-05-14
2025-12-31	$594,298	553	+15.0%	Shares	Sole	2026-02-13
2025-09-30	$367,003	481	-1.6%	Shares	Sole	2025-11-12
2025-06-30	$381,190	489	-20.2%	Shares	Sole	2025-08-11
2025-03-31	$506,282	613	+49.9%	Shares	Sole	2025-05-13
2024-12-31	$315,748	409	-9.1%	Shares	Sole	2025-01-29
2024-09-30	$398,673	450	-82.0%	Shares	Sole	2024-11-06
2024-06-30	$2,261,639	2,498	+8.4%	Shares	Sole	2024-08-14
2024-03-31	$1,792,419	2,304	-14.6%	Shares	Sole	2024-05-14
2023-12-31	$1,573,301	2,699	+19.6%	Shares	Sole	2024-02-14
2023-09-30	$1,212,302	2,257	-20.1%	Shares	Sole	2023-11-14
2023-06-30	$1,324,399	2,824	+12.1%	Shares	Sole	2023-08-14
2023-03-31	$865,074	2,519	+9.4%	Shares	Sole	2023-05-15
2022-12-31	$842,529	2,303	—	Shares	Sole	2023-05-25
No filing history on record for this holder in this stock.